Skip Navigation Links
Centers for Disease Control and Prevention
 CDC Home CDC HomeSearchHealth Topics A-Z
Travelers' Health
U.S. Department of Health and Human Services

Contents
 Destinations
 Outbreaks
 Diseases
 Vaccinations
 Insect/Arthropod Protection
 Safe Food and Water
 Travel Medicine Clinics
 Yellow Book 2003-2004
 Traveling with Children
 Special Needs Travelers
 Traveling with Pets
 Cruise Ships and Air Travel
 Illness and Injury Abroad
 Nonmedical Emergency Preparation
 Reference Materials
 Other Related Sites
 
 State and Local Health Departments
 Quarantine Stations
 Division of Global Migration and Quarantine
 GeoSentinel
Global Surveillance Network of ISTM & CDC
 National Center for Infectious Diseases
 USDA/APHIS 
Importing food, plant, animal products
 U.S. State Department
 Pan American Health Organization
 World Health Organization
The Yellow Book - Health Information for International Travel, 2003-2004
 
_

Amebiasis

Description

Amebiasis is caused by the protozoan parasite Entamoeba histolytica. Infection is acquired by the fecal-oral route, either by person-to-person contact or indirectly by eating or drinking fecally contaminated food or water.

Occurrence

Amebiasis occurs worldwide, especially in regions with poor sanitation.

Risk for Travelers

For travelers to low-income countries, risk for infection is highest for those who live in or visit rural areas, spend time in backcountry areas, or eat or drink in settings of poor sanitation.

Clinical Presentation

The incubation period is commonly 2–4 weeks but ranges from a few days to years. The clinical spectrum of intestinal amebiasis ranges from asymptomatic infection to fulminant colitis. Entamoeba dispar, which is nonpathogenic, cannot be distinguished from the pathogen E. histolytica by routine microscopy; however, an enzyme immunoassay kit for distinguishing the two organisms is commercially, but not widely available. In persons infected with E. histolytica who are symptomatic, the most common symptom is diarrhea. The diarrhea can evolve to painful, bloody bowel movements, with or without fever (amebic dysentery). Occasionally, amebiasis causes disease outside the intestinal tract, most notably in the liver (amebic liver abscess).

Prevention

No vaccine is available. Travelers to low-income countries should be advised to follow the precautions detailed in the section Risks from Food and Drink and avoid sexual practices that may lead to fecal-oral transmission.

Treatment

Travelers may be advised to consult with an infectious disease specialist to ensure proper diagnosis and treatment. Iodoquinol or paromomycin are the drugs of choice for asymptomatic but proven E. histolytica infections. For mild or moderate to severe intestinal disease and extraintestinal disease (e.g., hepatic abscess), treatment with metronidazole or tinidazole (not yet available in the United States) should be immediately followed by treatment with paromomycin or iodoquinol.

— Barbara Herwaldt, Jeff Jones


 Top of Page


Travelers' Health Home | Contact Us |

CDC Home | Search | Health Topics A-Z |

This page last reviewed June 30, 2003

Division of Global Migration and Quarantine |
National Center for Infectious Diseases |
Centers for Disease Control and Prevention |

CDC Privacy Policy | Accessibility |
 

Travelers' Health Home Contact Us Mexico and Central America Caribbean Tropical South America Temperate South America Western Europe Eastern Europe and the Newly Independent States of the former Soviet Union (NIS) Middle East North Africa West Africa East Africa Australia and the South Pacific East Asia Southeast Asia Central Africa Southern Africa Indian Subcontinent North America